NCT06319014

Brief Summary

The purpose of this study is to compare the effects of aerobic (AE), resistance (RE), and combination (AERE) exercise throughout pregnancy on selected maternal and fetal/neonatal physiological variables in women at-risk for preeclampsia. The central hypothesis of this project is that exercise will decrease severity and occurrence of preeclampsia symptoms, thus improving maternal, pregnancy, and birth outcomes. Aim 1. Determine the influence of different exercise modes during pregnancy at risk of preeclampsia on maternal cardiometabolic health. Aim 2. Determine the most effective exercise mode in pregnancy at risk of preeclampsia on improving birth and infant health outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
224

participants targeted

Target at P75+ for not_applicable

Timeline
5mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jun 2024Oct 2026

First Submitted

Initial submission to the registry

March 12, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 19, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

June 24, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

July 1, 2024

Status Verified

June 1, 2024

Enrollment Period

1.8 years

First QC Date

March 12, 2024

Last Update Submit

June 28, 2024

Conditions

Outcome Measures

Primary Outcomes (11)

  • Systolic Blood Pressure (16wks)

    resting SBP

    16 weeks gestation

  • Systolic Blood Pressure (20wks)

    resting SBP

    20 weeks gestation

  • Systolic Blood Pressure (24wks)

    resting SBP

    24 weeks gestation

  • Systolic Blood Pressure (28wks)

    resting SBP

    28 weeks gestation

  • Systolic Blood Pressure (32wks)

    resting SBP

    32 weeks gestation

  • Systolic Blood Pressure (36wks)

    resting SBP

    36 weeks gestation

  • Maternal Cardiometabolic Risk (CMR) Score

    summation of age- and sexstandardized z-scores for waist circumference (or BMI), triglycerides, systolic blood pressure (SBP), glucose (insulin or HOMA-IR), and inverse HDL, with a lower CMR score indicating lower risk

    during pregnancy

  • Symptom Occurrence

    maternal medical record and questionnaire data for occurrence, signs, and symptoms of hypertension/pre-eclampsia

    at delivery

  • Placental Efficiency

    placental weight gain and birth weight will be used to calculate placental efficiency

    at delivery

  • Birth Weight

    infant birth weight

    at delivery

  • Infant Cardiometabolic Risk (CMR) Score

    The CMR score will be a summation of age- and sex-standardized z-scores for abdominal circumference (or BMI),systolic blood pressure (SBP), glucose, and inverse HDL, with a lower CMR score indicating lower risk.

    at delivery

Secondary Outcomes (53)

  • Maternal Heart Rate (16wks)

    16 weeks gestation

  • Maternal Heart Rate (20wks)

    20 weeks gestation

  • Maternal Heart Rate (24wks)

    24 weeks gestation

  • Maternal Heart Rate (28wks)

    28 weeks gestation

  • Maternal Heart Rate (32wks)

    32 weeks gestation

  • +48 more secondary outcomes

Study Arms (4)

AE Group

EXPERIMENTAL

The AE group will exercise on aerobic machines (i.e. treadmill, elliptical, bicycle) All exercise participants will be prescribed exercise that meets guidelines of the American College of Obstetricians and Gynecologists (ACOG), American College of Sports Medicine (ACSM), and the American Heart Association (AHA); 150 minutes per week, moderate intensity (60-80% aerobic capacity, Rating of Perceived Exertion, RPE, 12-15) per week. These limits are the same as those that generated previous positive findings for our preliminary data.

Behavioral: Exercise Modes

RE Group

EXPERIMENTAL

The RE group will perform 12-15 repetitions of 10-12 resistance exercises in a circuit, for 3 sets, with a rest period of 30-60 seconds between sets as needed.\[172\] Seated isokinetic exercise using resistance machines will target all major muscle groups. Light dumbbells and resistance bands will be used if the participant is unable to lift the minimal load on machines. Core exercises will be performed at the end of the session (i.e. seated side bends) All exercise participants will be prescribed exercise that meets guidelines of the American College of Obstetricians and Gynecologists (ACOG), American College of Sports Medicine (ACSM), and the American Heart Association (AHA); 150 minutes per week, moderate intensity (60-80% aerobic capacity, Rating of Perceived Exertion, RPE, 12-15) per week. These limits are the same as those that generated previous positive findings for our preliminary data.

Behavioral: Exercise Modes

AERE Group

EXPERIMENTAL

AERE group will alternate between AE exercise and RE; for this group, RE exercises will consist of 1 set of 12-15 repetitions of 4 resistance exercises, then 5 minutes of AE, then repeat this cycle with different exercises. All exercise participants will be prescribed exercise that meets guidelines of the American College of Obstetricians and Gynecologists (ACOG), American College of Sports Medicine (ACSM), and the American Heart Association (AHA); 150 minutes per week, moderate intensity (60-80% aerobic capacity, Rating of Perceived Exertion, RPE, 12-15) per week. These limits are the same as those that generated previous positive findings for our preliminary data.

Behavioral: Exercise Modes

Control

NO INTERVENTION

The Control group will participate in weekly sessions that focus on stretching, breathing, and healthy lifestyle.

Interventions

Exercise ModesBEHAVIORAL

Moderate intensity aerobic exercise Moderate intensity resistance exercise Moderate intensity combination exercise

AE GroupAERE GroupRE Group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy women, age 18-40 years, \<16 weeks' gestation, with singleton pregnancy; women (BMI:18.5-45.0), sedentary, cleared by their obstetric provider.

You may not qualify if:

  • pre-existing chronic conditions such as HIV, lupus, etc.; taking medicines that affect fetal development; and/or lack of telephone or email contact information).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

East Carolina University

Greenville, North Carolina, 27834, United States

RECRUITING

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Linda E May, MS, PhD

    East Carolina University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Linda E May, MS, PhD

CONTACT

James DeVente, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Pregnant women will be randomized to one of four groups: aerobic exercise, resistance exercise, combination (aerobic + resistance), or control (no exercise). All exercise participants will be prescribed exercise that meets guidelines of the American College of Obstetricians and Gynecologists (ACOG), American College of Sports Medicine (ACSM), and the American Heart Association (AHA); 150 minutes per week, moderate intensity (60-80% aerobic capacity, Rating of Perceived Exertion, rating of perceived exertion (RPE), 12-15) per week. These limits are the same as those that generated previous positive findings for our preliminary data.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 12, 2024

First Posted

March 19, 2024

Study Start

June 24, 2024

Primary Completion

April 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

July 1, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

de-identified data can be shared upon request to researchers

Locations